Comparison of Glucose Control Profile in Patients With Depression and Type 2 Diabetes Receiving Bupropion or Venlafaxine: A Randomized Controlled Clinical Trial
Current Psychosomatic Research · 2023
DOI: 10.32598/cpr.1.3.32.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Psychosomatic Research, 2023. Verfasst von Mohammad Ali Bayani und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Diabetes mellitus, Depression
Abstract (Originalsprache)
Background and Objective This study aims to compare the effects of bupropion and venlafaxine on glucose control of patients with depression and type 2 diabetes (T2D). Materials & Methods TThis randomized controlled trial was carried out in endocrinology clinic affiliated to Babol University of Medical Sciences on adult patients with comorbid T2D and depression in two groups. The first group (n=19) received venlafaxine 37.5-150 mg daily, while the second group (n=16) was treated with bupropion 75-300 mg per day. The primary outcomes were the severity of depressive symptoms and the glucose control profile. Depressive symptoms were assessed with the Beck depression inventory (BDI). Data was analyzed in SPSS software, version 17 package. P
Zitieren
APA
Bayani, M. A., Nekoofar, N., Bijanii, A., & Moudi, S. (2023). Comparison of Glucose Control Profile in Patients With Depression and Type 2 Diabetes Receiving Bupropion or Venlafaxine: A Randomized Controlled Clinical Trial. Current Psychosomatic Research. https://doi.org/10.32598/cpr.1.3.32.1
Vancouver
Bayani MA, Nekoofar N, Bijanii A, Moudi S. Comparison of Glucose Control Profile in Patients With Depression and Type 2 Diabetes Receiving Bupropion or Venlafaxine: A Randomized Controlled Clinical Trial. Current Psychosomatic Research. 2023. doi:10.32598/cpr.1.3.32.1
BibTeX
@article{Bayani2023,
author = {Bayani, Mohammad Ali and Nekoofar, Nikta and Bijanii, Ali and Moudi, Sussan},
title = {Comparison of Glucose Control Profile in Patients With Depression and Type 2 Diabetes Receiving Bupropion or Venlafaxine: A Randomized Controlled Clinical Trial},
journal = {Current Psychosomatic Research},
year = {2023},
doi = {10.32598/cpr.1.3.32.1}
}
EUVIMED